Terms: = Sarcomas AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Treatment
6 results:
1. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies.
Hunt PJ; Amit M; Kabotyanski KE; Aashiq M; Hanna EY; Kupferman ME; Su SY; Gidley PW; Nader ME; DeMonte F; Raza SM
Neurosurg Rev; 2023 Jun; 46(1):157. PubMed ID: 37386212
[TBL] [Abstract] [Full Text] [Related]
2. fat1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic treatment.
Zhou C; Sun Y; Gong Z; Li J; Zhao X; Yang Q; Yu H; Ye J; Liang J; Jiang L; Zhang D; Shen Z; Zheng S
J Bone Miner Res; 2022 May; 37(5):885-895. PubMed ID: 35279875
[TBL] [Abstract] [Full Text] [Related]
3. Circfat1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells.
Liu G; Huang K; Jie Z; Wu Y; Chen J; Chen Z; Fang X; Shen S
Mol Cancer; 2018 Dec; 17(1):170. PubMed ID: 30514309
[TBL] [Abstract] [Full Text] [Related]
4. Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: A case report.
Ren W; Sun Q; Wu PY; Huang B; Yang J; Yan J; Liu BR
Medicine (Baltimore); 2018 Nov; 97(48):e13413. PubMed ID: 30508944
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
[TBL] [Abstract] [Full Text] [Related]
6. treatment experience: locally advanced sarcomas with 15 MeV fast neutrons.
Ornitz R; Herskovic A; Schell M; Fender F; Rogers CC
Cancer; 1980 Jun; 45(11):2712-6. PubMed ID: 6769582
[TBL] [Abstract] [Full Text] [Related]
